EUVIMED · CrossrefZeitschrift
The EANM Journal
ISSN 3051-2921 · Elsevier BV
Neueste Artikel
European Association of Nuclear Medicine (EANM) Focus Meeting 7: Consensus on the role of molecular imaging and fluid biomarkers in diagnosis, treatment eligibility, and monitoring in Alzheimer's Disease
Imaging more, changing nothing: Are there predictors of unchanged management after [18F]PSMA-1007 PET/CT in primary staging of high-risk prostate cancer?
68Ga-PSMA-11 PET/CT in Selected Non-Prostatic Malignancies: Results from the Prospective Monocentric MORE-PSMA Registry
[68Ga]Ga-OncoACP3 PET imaging defines acid phosphatase 3 as a clinically actionable theranostic target in prostate cancer: a prospective phase I trial
Joint EANM, IAEA, and SNMMI practical guidance on somatostatin receptor-targeted radionuclide therapy of neuroendocrine tumours
Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease
Fully automated deep learning-based algorithm for contouring primary malignancy on PSMA PET/CT: results from the proPSMA trial in men with intermediate to high-risk prostate cancer
Prognostic value of PSMA PET in metachronous oligometastatic prostate cancer
European association of nuclear medicine (EANM) focus meeting 6 consensus on molecular imaging in breast cancer (endorsed by EUSOBI, ESSO, ESTRO, EuropaDonna)
Perspectives of the European Association of Nuclear Medicine (EANM) on early perfusion imaging in the context of amyloid PET imaging protocols
[18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0
Why not a new journal?
A glass to the past, a toast to the future: Forty years of EANM
Prospects of PET/MR: the 5th Chinese PET/MR academic symposium
A roadmap for AI-aided digital twins in computational nuclear oncology: A position paper by the EANM
EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!
Brain [18F]FDG-PET databases after the COVID-19 pandemia: Rethinking normality
Systematic analysis of amino acid PET use in Germany: strategic considerations for widespread clinical application
E pluribus unum. Interdisciplinary cooperation on issues pertaining to the role of nuclear medicine in the treatment of differentiated thyroid cancer: a commentary on the 2025 American Thyroid Association guidelines
Endoscopic ultrasonography (EUS)-guided SSTR PET/CT imaging in the management of patients with small (
Safety, dosimetry and preliminary imaging findings of [68Ga]Ga-OncoFAP – a prospective multicenter Phase I clinical trial
Total lesion glycolysis outperforms visual total vascular score on 18F-FDG-PET/CT as biomarker in giant cell arteritis
EANM nuclear medicine workforce survey: Sentiments, gaps, and strategic priorities in Europe
SUV harmonization in the era of advanced PET: a necessary recalibration
Health technology assessment in nuclear medicine: Challenges and opportunities in Europe
Which SUV is more stable for PSMA-positivity thresholding? EARL harmonized lesional SUV versus reference tissue SUV
Celebrating 85 years of radioiodine: Saul Hertz and the foundations of theranostic precision medicine
Model-based cost-effectiveness analysis of [18F]FDG PET/CT early into therapy with immune checkpoint inhibitors: Tackling pseudoprogression in unresectable cutaneous melanoma patients
An investigation of the APOE4 association with tau pathology and cognitive decline
EANM 2025 editors’ choices
EUVIMED